Measuring and reducing autism symptoms
Part of Mental health clinical trials.
This study tests a new platform designed to measure and reduce autism symptoms in children ages 2 to 8. It may help if your child has an autism diagnosis and is not taking psychiatric medications.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your child must be between 2 and 8 years old.
- Your child must have an autism spectrum disorder diagnosis.
- Your child must score between 30 and 45 on a standard autism assessment (CARS-2).
- Your child cannot be taking any psychiatric medications.
- Your child cannot have a history of seizures or an abnormal EEG.
- Your child cannot have skin lesions on the scalp or implanted devices like cochlear implants.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks for the best way to improve sleep in children with autism who have ongoing insomnia. You and your child will complete sleep tracking and participate in an insomnia treatment plan to reduce trouble falling asleep, staying asleep, or waking too early.
This trial tests if non-invasive near-infrared light stimulation can help people with autism. It is open to individuals aged 4 to 60.
This study tests a noninvasive brain stimulation approach (through the scalp) to see if it can help children with autism spectrum disorder. Families may be asked about the child’s development, communication level, and medical history to make sure the treatment is safe.
This study tests a non-invasive brain stimulation technique called transcranial temporal interference stimulation (a safe electrical method applied to the scalp) to help improve symptoms in children with autism spectrum disorder (ASD). The goal is to see if this treatment can help with social communication, behavior, and other autism-related challenges.
This trial studies whether N-acetylcysteine, a medicine taken by mouth, can improve autism-related restricted and repetitive behaviors in children. It looks at children who are showing at least moderate severity in these behaviors and may involve brain testing for safety reasons.
This trial tests an oral liquid medicine (called NTI164) to see if it helps reduce symptoms of autism in children and teens. It may be an option if current treatments haven't fully helped, but it requires regular study visits and certain health rules.
Hear when a new Autism spectrum disorder trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.